May 23 (Reuters) - Cytotools AG T5OG.DE :
* Results from the phase II / III trial for the treatment of
leg ulcers (venous leg ulcer, ulcerated leg) confirmed for the
first time a clinical efficacy of DermaPro in this indication
* In treatment of leg ulcers with DermaPro a complete wound
closure was achieved in 50% of treated patients
* Wound size in leg ulcer decreased by 62% compared to
initial level with DermaPro treatment
Source text for Eikon: ID:nEQ8Hpmkfa
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))